Centene's stock plunge offers a potential long-term opportunity. Click here for a full investment analysis of CNC stock.

This conjecture is not overly bullish as well, as similarly observed in UNH's ongoing recovery from the May 2025 P/E bottom ...

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector.

July 2 was indisputably disastrous. Shares closed down by over 40% that day, resulting in the firm losing over $11 billion in ...

Centene shares plummeted Wednesday after the managed-care company withdrew its full-year outlook after receiving new data ...

Morgan Stanley initiated coverage with an Overweight rating and a $70 price target, highlighting Centene’s growth opportunities in the Medicaid and Medicare markets.

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector.

The firm reiterated its Buy rating and $73.00 price target on Centene stock despite the guidance withdrawal. Centene’s previous 2025 adjusted EPS guidance was "greater than" $7.25 per share, but the ...

Centene Corp shares fell 25% in after-market trading on Tuesday after the health insurer withdrew its 2025 earnings guidance due to a $1.8 billion shortfall in expected risk adjustment revenue ...

Shares of health insurance provider Elevance Health (NYSE:EVH) fell 9.9% in the afternoon session after peer, Centene pulled its full-year financial guidance, triggering a sector-wide sell-off.

Intel shares jumped Tuesday following news the embattled chipmaker plans to slash hundreds of jobs as part of previously ...

Centene (CNC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising ...